Monopar Therapeutics Inc.MNPRNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+27.1%
5Y CAGR+27.1%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+27.1%/yr
vs +33.4%/yr prior
5Y CAGR
+27.1%/yr
Consistent
Acceleration
-6.3pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.3x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$21.62M+33.8%
2024$16.16M+83.0%
2023$8.83M-16.2%
2022$10.54M+15.4%
2021$9.13M+40.2%
2020$6.51M+50.5%
2019$4.32M+29.8%
2018$3.33M-79.9%
2017$16.60M+1291.9%
2016$1.19M-